AVNR’s PR on Otsuka buyout: http://finance.yahoo.com/news/avanir-pharmaceuticals-acquired-otsuka-pharmaceutical-083500983.html Avanir Pharmaceuticals, Inc. (AVNR) today announced that it has entered into a definitive agreement with Otsuka Pharmaceutical Co., Ltd. pursuant to which Otsuka will acquire Avanir for $17.00 per share in cash. The transaction, which values Avanir at approximately $3.5 billion, has been unanimously approved by the boards of directors of both companies. Otsuka will launch a tender offer within ten business days to purchase all outstanding shares of Avanir. The buyout price is a modest 13% premium to AVNR’s closing price yesterday.